| Literature DB >> 34094684 |
Yun-Ju Lai1,2, Chi-Hong Chao3,4,5, Chun-Che Liao1, Te-An Lee1, Jung-Mao Hsu6, Wen-Cheng Chou1, Jyun Wang1, Hsiang-Chi Huang1, Shing-Jyh Chang7, Yi-Ling Lin1,8, Chia-Wei Li1.
Abstract
The engagement of human angiotensin-converting enzyme 2 (hACE2) and SARS-CoV-2 spike protein facilitate virus spread. Thus far, ACE2 and TMPRSS2 expression is correlated with the epithelial-mesenchymal transition (EMT) gene signature in lung cancer. However, the mechanism for SARS-CoV-2-induced EMT has not been thoroughly explored. Here, we showed that SARS-CoV-2 induces EMT phenotypic change and stemness in breast cancer cell model and subsequently identified Snail as a modulator for this regulation. The in-depth analysis identifies the spike protein (S), but not envelope (E), nucleocapsid (N), or membrane protein (M), of SARS-CoV-2 induces EMT marker changes. Suppression of Snail expression in these cells abrogates S protein-induced invasion, migration, stemness, and lung metastasis, suggesting that Snail is required for SARS-CoV-2-mediated aggressive phenotype in cancer. This study reveals an important oncogenic role of SARS-CoV-2 in triggering breast cancer metastasis through Snail upregulation. AJCREntities:
Keywords: ACE2; EMT; SARS-CoV-2; Snail; TMPRSS2; epithelial-mesenchymal transition; spike
Year: 2021 PMID: 34094684 PMCID: PMC8167694
Source DB: PubMed Journal: Am J Cancer Res ISSN: 2156-6976 Impact factor: 6.166